These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33784790)

  • 21. Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis.
    Hussain RM; Tran KD; Maguire AM; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):661-663. PubMed ID: 31671202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dog models for blinding inherited retinal dystrophies.
    Petersen-Jones SM; Komáromy AM
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):15-26. PubMed ID: 25671556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leber's Congenital Amaurosis: Current Concepts of Genotype-Phenotype Correlations.
    Huang CH; Yang CM; Yang CH; Hou YC; Chen TC
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An optometrist's guide to the top candidate inherited retinal diseases for gene therapy.
    O'Hare F; Edwards TL; Hu ML; Hickey DG; Zhang AC; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):431-443. PubMed ID: 33689629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions.
    Kumaran N; Moore AT; Weleber RG; Michaelides M
    Br J Ophthalmol; 2017 Sep; 101(9):1147-1154. PubMed ID: 28689169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Editing Tools for Gene Therapy in Inherited Retinal Dystrophies.
    Pulman J; Sahel JA; Dalkara D
    CRISPR J; 2022 Jun; 5(3):377-388. PubMed ID: 35506982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy for inherited retinal diseases.
    Nuzbrokh Y; Ragi SD; Tsang SH
    Ann Transl Med; 2021 Aug; 9(15):1278. PubMed ID: 34532415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leber congenital amaurosis: Current genetic basis, scope for genetic testing and personalized medicine.
    Kondkar AA; Abu-Amero KK
    Exp Eye Res; 2019 Dec; 189():107834. PubMed ID: 31639339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Systematic Review and Meta-Analyses of Interventional Clinical Trial Studies for Gene Therapies for the Inherited Retinal Degenerations (IRDs).
    Tuohy GP; Megaw R
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34069580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene and Cell Therapy for AIPL1-Associated Leber Congenital Amaurosis: Challenges and Prospects.
    Perdigao PRL; van der Spuy J
    Adv Exp Med Biol; 2019; 1185():97-101. PubMed ID: 31884595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.
    Simonelli F; Maguire AM; Testa F; Pierce EA; Mingozzi F; Bennicelli JL; Rossi S; Marshall K; Banfi S; Surace EM; Sun J; Redmond TM; Zhu X; Shindler KS; Ying GS; Ziviello C; Acerra C; Wright JF; McDonnell JW; High KA; Bennett J; Auricchio A
    Mol Ther; 2010 Mar; 18(3):643-50. PubMed ID: 19953081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis.
    Rakoczy EP; Narfström K
    Int J Biochem Cell Biol; 2014 Nov; 56():153-7. PubMed ID: 25286304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Management of Patients with RPE65 Mutation-Associated Inherited Retinal Degenerations in Europe: Results of a Multinational Survey by the European Vision Institute Clinical Research Network.
    Lorenz B; Tavares J; van den Born LI; Marques JP; Scholl HPN;
    Ophthalmic Res; 2021; 64(5):740-753. PubMed ID: 33684911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The new landscape of retinal gene therapy.
    Ku CA; Pennesi ME
    Am J Med Genet C Semin Med Genet; 2020 Sep; 184(3):846-859. PubMed ID: 32888388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration.
    Fuller-Carter PI; Basiri H; Harvey AR; Carvalho LS
    BioDrugs; 2020 Dec; 34(6):763-781. PubMed ID: 33136237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.
    Stein L; Roy K; Lei L; Kaushal S
    Expert Opin Biol Ther; 2011 Mar; 11(3):429-39. PubMed ID: 21299439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on gene therapies in pediatric ophthalmology.
    Bremond-Gignac D; Robert MP; Daruich A
    Arch Pediatr; 2023 Nov; 30(8S1):8S41-8S45. PubMed ID: 38043982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-Editing Strategies for Treating Human Retinal Degenerations.
    Quinn J; Musa A; Kantor A; McClements ME; Cehajic-Kapetanovic J; MacLaren RE; Xue K
    Hum Gene Ther; 2021 Mar; 32(5-6):247-259. PubMed ID: 32993386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Mini-Review: Leber Congenital Amaurosis: Identification of Disease-Causing Variants and Personalised Therapies.
    Thompson JA; De Roach JN; McLaren TL; Lamey TM
    Adv Exp Med Biol; 2018; 1074():265-271. PubMed ID: 29721952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense Oligonucleotide Therapy for Inherited Retinal Dystrophies.
    Gerard X; Garanto A; Rozet JM; Collin RW
    Adv Exp Med Biol; 2016; 854():517-24. PubMed ID: 26427454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.